AHA: Other Defibrillation Strategies Studied for Refractory V-Fib
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with refractory ventricular fibrillation during out-of-hospital cardiac arrest, use of double sequential external defibrillation (DSED) or vector-change (VC) defibrillation results in better sur…
Learn MoreOptions Explored for MM That Relapses After BCMA CAR T Therapy
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Patients with multiple myeloma that relapses after B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR T) therapy can potentially be treated with multiple lines of salvage therapy…
Learn MoreASN: Empagliflozin Cuts Risk for Progression in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with chronic kidney disease at risk for progression, the risk for progression of kidney disease or death from cardiovascular causes is reduced with empagliflozin treatment, according to a study …
Learn MoreUnexplained Outpatient Electrolyte Abnormality May Signal Eating Disorder
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Nearly one in five individuals diagnosed with an eating disorder had a preceding outpatient electrolyte abnormality, according to a study published online Nov. 8 in JAMA Network Open.Gregory L. Hundemer, M.D…
Learn MoreStandard Testosterone Threshold Not Accurate for Younger Men
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Age-specific cutoff points for low testosterone among men aged 20 to 44 years are substantially higher than the standard cutoff point, according to a study published online Oct. 25 in The Journal of Urology….
Learn MoreASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreMyocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American Colle…
Learn MoreMyocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American Colle…
Learn MoreLinks Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years a…
Learn More